Literature DB >> 31779818

Parkinsonism in diseases predominantly presenting with dystonia.

Alessio Di Fonzo1, Giulia Franco1, Paolo Barone2, Roberto Erro2.   

Abstract

If the presence of dystonia is a well-recognized phenomenon in disorders predominantly presenting with parkinsonism, including sporadic Parkinson Disease, the term dystonia-parkinsonism usually refers to rare conditions, often genetic, in which the severity of dystonia usually equates that of parkinsonism. At variance with parkinsonian syndromes with additional dystonia, the conditions reviewed in this chapter have usually their onset in childhood and their diagnostic work-up is different. In fact, the phenotype is not usually specific of the underlying defect and additional investigations are therefore required. Here, we review the diseases predominantly presenting with dystonia where parkinsonism can develop, according to their main pathophysiological mechanism including disorders of dopamine biosynthesis, neurotransmitter transporter disorders, disorder of metal metabolism (i.e., iron, copper and manganese) and other inherited dystonia-parkinsonism conditions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP1A3; DRD; DYT; Dystonia-parkinsonism; Iron accumulation; NBIA; Neurotransmitter transporters; PRKRA; TAF1; Wilson disease

Mesh:

Year:  2019        PMID: 31779818     DOI: 10.1016/bs.irn.2019.10.007

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  2 in total

1.  Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study.

Authors:  Angelo Pascarella; Lucia Manzo; Anna Estraneo
Journal:  Neurol Sci       Date:  2022-10-12       Impact factor: 3.830

2.  Oculogyric Crisis in a Girl with Infantile Parkinsonism-Dystonia-2.

Authors:  Bhanudeep Singanamalla; Gurpreet Kochar; Arushi Gahlot Saini
Journal:  Ann Indian Acad Neurol       Date:  2021-08-05       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.